Responses
Immune cell therapies and immune cell engineering
Original research
Deletion of the protein tyrosine phosphatase PTPN22 for adoptive T cell therapy facilitates CTL effector function but promotes T cell exhaustion
Compose a Response to This Article
Other responses
No responses have been published for this article.
